![Jennifer Sy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Sy
Comptroller/Controller/Auditor chez
AEON BIOPHARMA, INC.
Fortune : - $ au 31/07/2026
Profil
Jennifer Sy is currently Chief Accounting Officer at AEON Biopharma, Inc., starting in 2026.
Formerly, Ms. Sy was Controller at Nogin, Inc. from 2021 to 2023.
Ms. Sy completed undergraduate studies at the University of California, Los Angeles.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/04/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Jennifer Sy
| Sociétés | Poste | Début |
|---|---|---|
| AEON BIOPHARMA, INC. | Comptroller/Controller/Auditor | 01/08/2023 |
Anciens postes connus de Jennifer Sy
| Sociétés | Poste | Fin |
|---|---|---|
| NOGIN, INC. | Comptroller/Controller/Auditor | 01/05/2023 |
Formation de Jennifer Sy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nogin, Inc.
 Nogin, Inc. Chemicals: AgriculturalProcess Industries Operates as an ecommerce platform that includes research and development, sales optimization, and machine learning | Process Industries |
AEON Biopharma, Inc.
 AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets | Health Technology |
